CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE2795.35-6.1 (-0.22 %)
PREV CLOSE () 2801.45
OPEN PRICE () 2797.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1106
TODAY'S LOW / HIGH ()2745.45 2808.00
52 WK LOW / HIGH ()1950.65 3485.75
NSE2790.90-12.85 (-0.46 %)
PREV CLOSE() 2803.75
OPEN PRICE () 2790.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2790.90 (4)
VOLUME 90050
TODAY'S LOW / HIGH() 2751.90 2807.50
52 WK LOW / HIGH ()1952 3485
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1979

Management Info :

Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director

Registered Office :

Address : Ajanta House,Charkop ,Kandivali (West),
Mumbai,
Maharashtra-400067

Phone : 022-66061000

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
10Sep Ajanta Pharma informs about disclosure
Ajanta Pharma has informed that the exchange has received Disclosure und..
23Aug Ajanta Pharma informs about loss of sh
Pursuant to Regulation 39(3) of the SEBI LODR Regulations and in terms o..
21Aug Ajanta Pharma informs about disclosure
Ajanta Pharma has informed that the exchange has received Disclosure und..
08Aug Ajanta Pharma informs about participat
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
31Jul Ajanta Pharma moves up on reporting 18
Ajanta Pharma is currently trading at Rs. 2620.00, up by 97.25 points or..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit2349.88072.40000000001
Gross Profit 3092 10969.5
Operating Profit 3432.512359.1
Net Sales 11289.139711.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 28633.50 (0.60%)
M.Cap ( in Cr)
60844.19
Divi's Lab (BSE)
 5880.45 (1.67%)
M.Cap ( in Cr)
156107.47
Innova Captab (BSE)
 1059.10 (8.12%)
M.Cap ( in Cr)
6060.69
Pfizer (BSE)
 4875.60 (1.40%)
M.Cap ( in Cr)
22304.76
Procter&Gamble Healt (BSE)
 5446.35 (0.91%)
M.Cap ( in Cr)
9040.60
Shareholding Pattern
PROMOTERS 66.26%
MUTUAL FUNDS/UTI 14.93%
NON-INSTITUTION 7.52%
FI/BANKS/INSURANCE 1.57%
GOVERNMENT 0.01%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX78472.48-0.39 (0.00%)
NIFTY23750.2022.55 (0.10%)
Dow Jones 43297.03390.08 (0.91%)
Nasdaq 20031.13266.25 (1.35%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI